Hormone therapy for prostate cancer

被引:0
|
作者
David, Claire [1 ]
Boinet, Tomas [2 ]
机构
[1] Ctr Hosp St Calais, Serv Pharm, 2 Rue Perrine, F-72120 St Calais, France
[2] Ctr Municipal Sante, Rue Petit Train, F-72160 Connerre, France
来源
ACTUALITES PHARMACEUTIQUES | 2019年 / 58卷 / 583期
关键词
benign prostatic hyperplasia; hormone dependent cancer; oral hormone therapy; prostate-specific antigen;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Prostate cancer is the most common cancer in men in France. Its specialised treatment must take into account the patient's age, comorbidities and informed choices to avoid harmful overdiagnosis and overtreatment. Overall, it is a cancer with a good prognosis, now further improved by new anti-hormonal and cytotoxic chemotherapy strategies. This codified strategy includes notably oral hormone therapy dispensed in the community pharmacy and thereby involving the community pharmacist. (C) 2018 Elsevier Masson SAS. All rights reserved
引用
收藏
页码:13 / 17
页数:5
相关论文
共 50 条
  • [1] HORMONE THERAPY IN CANCER OF PROSTATE
    KLOSTERHALFEN, H
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1977, 102 (25) : 947 - 947
  • [2] Hormone Therapy in Prostate Cancer
    Currie, Geoffrey M.
    Haase, Matthew
    Hashmi, Rashid
    Kiat, Hosen
    [J]. JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY, 2013, 41 (01) : 49 - 51
  • [3] Hormone therapy for prostate cancer
    Théodore, C
    [J]. BULLETIN DU CANCER, 2004, 91 (01) : 69 - 74
  • [4] Hormone therapy for prostate cancer
    Koltz, L.
    [J]. EJC SUPPLEMENTS, 2007, 5 (05): : 415 - 417
  • [5] Hormone therapy in prostate cancer
    Rocco, F
    Gadda, F
    Rocco, B
    Acquati, P
    Grisotto, M
    [J]. TUMORI JOURNAL, 2001, 87 (04): : S52 - S54
  • [6] Aspirin and hormone therapy for prostate cancer
    D'Amico, Anthony V.
    Kantoff, Philip W.
    Chen, Ming-Hui
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (26): : 2737 - 2738
  • [7] Hormone therapy for radiorecurrent prostate cancer
    H. Payne
    A. Khan
    S. Chowdhury
    R. Davda
    [J]. World Journal of Urology, 2013, 31 : 1333 - 1338
  • [8] Hormone therapy for radiorecurrent prostate cancer
    Payne, H.
    Khan, A.
    Chowdhury, S.
    Davda, R.
    [J]. WORLD JOURNAL OF UROLOGY, 2013, 31 (06) : 1333 - 1338
  • [9] Hormone therapy in advanced prostate cancer
    Forster, TH
    Stoffel, F
    Gasser, TC
    [J]. CONTROVERSIES IN URO-ONCOLOGY, 2002, 36 : 49 - 65
  • [10] Timing of hormone therapy for prostate cancer
    Baker, Holly
    [J]. LANCET ONCOLOGY, 2013, 14 (06): : E203 - E203